Synopsis The global Stress Management market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Stress Management is estimate.....
SynopsisTetanus is an infectious disease caused by Clostridium tetani characterized by muscle spasms. The global Tetanus Toxoid Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the fo.....
SynopsisThe global Suture Buttons market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Suture Buttons is estimated to increase from $ mill.....
SynopsisThe global Microneedling Devices in Aesthetic Medicine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Microneedling Devices .....
SynopsisRestless legs syndrome (RLS) is a neurological disease. RLS is also called as Willis-Ekbom disease. Patients suffering from RLS disease have an irresistible desire to move their feet. The continual movement of the legs leads to pain in the limbs, which leads t.....
Synopsis Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnolog.....
SynopsisThe global Digital Dentistry Equipment market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while e.....
SynopsisGlobal Autism Spectrum Disorder (ASD) Treatment Drugs market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Ru.....
SynopsisThe global Lucentis (Ranibizumab) and Biosimilar market size was valued at USD 1156.5 million in 2022 and is forecast to a readjusted size of USD 971.5 million by 2029 with a CAGR of -2.5% during review period. The influence of COVID-19 and the Russia-Ukraine .....
SynopsisThe global Implantable Cardiac Resynchronization Therapy Devices market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Implantable Cardiac Resynchronizatio.....
